Subset analysis of patients whose ALS did not progress from a long-term survival study showed NP001 saved lung function and extended life by 22 months vs. a control group (~70% on riluzole) NP001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback